Search - tctmd.com

Presenter: Jang Hoon Lee, Kyun Hee Kim, Won Suk Choi, Sun Hee Park, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Shung Chull Chae, Jae Eun Jun, Myung Ho Jeong, Young Jo Kim

January 03, 2012

Presentation TCT 2012

Impact Of Pre-Hospital Activation Strategy On Revascularization Time, Left Ventricular Ejection Fraction and Mortality In Patients With ST-Elevation Myocardial Infarction.

Presenter: Sofia A. Horvath, Ke Xu, Francis Nwanyanwu, Richard Chan, Luis Correa, Nouri Nass, Abdul-Rahman Jaraki, David Jurkovich, Richard Kennedy, Paul A. Vignola, Roberto J. Cubeddu

January 03, 2012

Presentation TCT 2012

Comparison of Clinical Outcomes between Infarct-Related Artery Revascularization only and Multivessel revascularization in Patients with Acute Myocardial Infarction and...

Presenter: Ju Yeol Baek, Ki Bae Seung, Hun Jun Park, Yong-Mo Yang, Won Iik Lee, Pum Joon Kim, Mahn Won Park, Yoon Seok Koh, Ki Yuk Chang, Myung Ho Jeong, Seung Jung Park

January 03, 2012

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Conference News

New Stem Cell Therapies Promising in Severe Heart Disease

November 06, 2011

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. David Wood About the COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease

September 28, 2019

Advertisement

FFR Guidance Remains Safe, Valuable in More Complex Disease

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Keynote Address Focuses on Newer DES, Problematic Subgroups

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

SMILE: One-Stage PCI Superior for Non-STEMI and Multivessel CAD

ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES

High-Dose Statins before PCI Improved Outcomes in NSTE-ACS

Thrombectomy Fails to Reduce Microvascular Obstruction in Non-STEMI

SMART-CASE: Conservative Revascularization Noninferior to Aggressive Approach

Prognostic Impact of Non-Infarct-Related-Artery Chronic Total Occlusion Revascularization in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty

Impact of Vessel Size on Angiographic and Clinical Outcomes of Revascularization with Drug-Eluting Stent in Patients with Acute Myocardial Infarction

Impact of New-Onset Acute Heart Failure in Patients with Acute Myocardial infarction Underwent Successful Revascularization

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

Second-Generation DES Safer, More Effective Than BMS in STEMI at 1 Year

The impact of revascularization and optimal medical therapy on six-month clinical outcome in patients with and without congestive heart failure after acute myocardial infarction

Impact Of Pre-Hospital Activation Strategy On Revascularization Time, Left Ventricular Ejection Fraction and Mortality In Patients With ST-Elevation Myocardial Infarction.

Comparison of Clinical Outcomes between Infarct-Related Artery Revascularization only and Multivessel revascularization in Patients with Acute Myocardial Infarction and...

Two New SES Show Improvement Over First-Generation Stents

New Stem Cell Therapies Promising in Severe Heart Disease

Dr. C. Michael Gibson Talks With Dr. David Wood About the COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content